as the healthcare flagship of alibaba group holding limited (alibaba holding, together with its subsidiaries, alibaba group), alibaba health information technology limited (the company) and its subsidiaries (the group) have been committed to developing internet technology and establishing a service ecology platform to provide industry partners with technical capabilities such as big data, cloud computing, artificial intelligence and internet of things, as well as service capabilities such as operational, quality control and customer service capabilities.
with our mission of making good health achievable at the fingertips and our vision of facilitating medicines through big data and using the internet to change the face of healthcare, to provide fair, affordable and accessible medical and healthcare services to 1 billion people, the group has worked hard to develop its pharmaceutical e-commerce, intelligent medicine and product tracking system services businesses during the financial year ended march 31, 2017.
compared to chinas huge pharmaceutical market, pharmaceutical e-commerce in china is still at a nascent stage of development, with pharmaceutical e-commerce making up only approximately 3% of pharmaceutical sales in china, which means there is still huge potential for its development. in addition, chinas retail pharmacies are currently undergoing an upgrade and transformation through chain operation, e-commerce, supply chain optimization and greater 
the group aspires to create an internet-based drug distribution and sales system that covers the entire industry chain, thereby enhancing the efficiency of the healthcare product supply chain and bringing benefits to all market participants and consumers. it commenced its own pharmaceutical e-commerce business this year, and leveraging on its operational branding strengths and owing to the efficient execution of its business team, the group quickly established the supporting systems for warehousing, logistics and customer services. this has facilitated the rapid growth of its pharmaceutical e-commerce business. the group also commenced the provision of merchants business development, merchant customer services, technical support and other outsourced and value-added services for certain pharmaceutical-related categories on the tmall platform in consideration for relevant service fees received from tmall.
in addition, the group began to develop centralized procurement and distribution operations for the pharmaceutical supply chain, starting by analyzing circulation data at the supply chain upstream to better provide quality products at competitive prices to downstream businesses. at the same time, the group also rolled out a new online and offline integrated retail channel covering the full chain by combining b2c and o2o businesses.
in relation to intelligent medicine, the group actively organized the provision of online health consultation services by pharmaceutical professionals through end-user applications such as the ali health mobile application, and the taobao, tmall and alipay mobile applications, allowing users to easily obtain real-time professional guidance. the group has also actively established a personal health management platform through which personal health reports are compiled using smart devices and artificial intelligence engines, and personalized health management services can be provided 
the prc government has implemented a number of healthcare reform initiatives to encourage tiered medical consultation and treatment and doctors to practise at multiple locations. the group will continue to actively explore the construction of an internet-based tiered medical service network through the internet hospital model, to facilitate optimization of medical resource allocation by medical institutions. furthermore, the group has invested significant manpower and other resources towards the integration of online and offline medical data, and is cooperating with quality hospitals and experts in the medical sector to develop artificial intelligence medical analysis engines and to actively explore technology extension and product forms for intelligent medicine, with the aim of helping medical institutions to enhance their efficiency in terms of technological research, operation and diagnosis. meanwhile, the group is also exploring investment opportunities in these areas. the group, together with those who share our vision, will explore the creation of personalized electronic health records for the public through the application of internet technology and artificial intelligence, to promote integrated healthcare services covering prevention, treatment, rehabilitation and health management throughout the full life cycle.
in relation to the construction of our product tracking system, in addition to our continued operation of the product identification, authentication and tracking system for the drug industry (drug piats) under the policy guidance of the china food and drug administration, the group has leveraged on its prior accumulated technical and operational experience and launched its ma shang fang xin () tracking platform, which offers product tracking and related value-added services to help manufacturers properly establish product tracking systems and realize quality assurance and marketing control, and to provide consumers with a terminal tool for scanning codes to trace product origin. as at the end of the year ended march 31, 2017, more than 5,000 enterprises from the drug, food and nutritional supplement industries had signed up with the group to join its ma shang fang xin platform, among which the number of pharmaceutical manufacturers which signed up accounted for more than half of the total number of pharmaceutical manufacturers in china.
with strong support from alibaba group and our ongoing investment in the expansion of strategic businesses and in nurturing talent, we believe that the group is well-positioned to satisfy the considerable demand in chinas healthcare market and that our business will maintain strong growth in the next few years. finally, i would like to take this opportunity to express my sincere gratitude to our shareholders, business partners, product users, and all of our staff for their long and unwavering support.

may 16, 2017 